Galectin Therapeutics Inc.
GALT
$1.38
$0.010.73%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -41.08% | 32.89% | 42.48% | 32.34% | 38.02% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -49.80% | 28.58% | 12.45% | 8.67% | 4.61% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 18,333.33% | -- | -- | -- | 0.00% |
| Total Current Assets | -37.74% | 32.65% | 40.16% | 30.22% | 34.83% |
|
|
|||||
| Total Current Assets | -37.74% | 32.65% | 40.16% | 30.22% | 34.83% |
| Net Property, Plant & Equipment | -65.22% | -58.06% | -50.00% | -42.31% | -46.51% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -48.87% | -42.86% | -38.67% | -35.29% | -31.38% |
| Total Assets | -37.96% | 30.72% | 37.72% | 28.01% | 32.49% |
|
|
|||||
| Total Accounts Payable | -12.05% | 4.25% | 87.15% | 48.73% | 65.32% |
| Total Accrued Expenses | -10.41% | 48.20% | 37.38% | -1.68% | 1.31% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 45,847.83% | 23,344.44% | 2.33% | 14.29% | 15.00% |
| Total Finance Division Other Current Liabilities | 585.71% | -- | -1.56% | -- | -1.56% |
| Total Other Current Liabilities | 585.71% | -- | -1.56% | -- | -1.56% |
| Total Current Liabilities | 125.88% | 140.05% | 46.86% | 9.54% | 20.47% |
|
|
|||||
| Total Current Liabilities | 125.88% | 140.05% | 46.86% | 9.54% | 20.47% |
| Long-Term Debt | 18.63% | 50.50% | 52.62% | 64.45% | 80.13% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -87.27% | -69.70% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -95.32% | -- | 176,300.00% | -- | 75.22% |
| Total Liabilities | 36.32% | 66.29% | 54.20% | 54.25% | 65.38% |
|
|
|||||
| Common Stock & APIC | 1.50% | 1.25% | 6.15% | 5.92% | 6.09% |
| Retained Earnings | -13.32% | -13.14% | -14.54% | -13.94% | -14.47% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -68.57% | -78.33% | -58.11% | -63.35% | -81.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | -0.45% | -0.45% | -0.45% | -0.45% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | -0.45% | -0.45% | -0.45% | -0.45% |
|
|
|||||
| Total Common Equity | -68.57% | -78.33% | -58.11% | -63.35% | -81.44% |
| Total Preferred Equity | 0.00% | -0.45% | -0.45% | -0.45% | -0.45% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -71.10% | -81.79% | -60.67% | -66.69% | -87.12% |
|
|
|||||